Publications

Recent Publications

270.     Fast Release of Lipophilic Agents from Circulating PEG-PDLLA Micelles Revealed by in Vivo Forster Resonance Energy Transfer Imaging. Chen, H., Kim, S., He, W., Wang, H., Low, P.S., Park, K. and Cheng, J.X. Langmuir 24, 5213-5217 (2008).

271.     A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Xia W., Hilgenbrink A.R., Matteson E.L., Lockwood M.B., Cheng J.X., Low P.S. Blood 113, 438-46, (2009).
 

272.     Folate-Targeted Hapten Immunotherapy of Adjuvant-Induced Arthritis: Comparison of Hapten Potencies. Yi, Y.S., Ayala-Lopez, W., Kularatne, S.A., Low, P.S. Molecular Pharmaceutics, 6, 1228-1236 (2009).

273.     Imaging of the Diffusion of Single Band 3 Molecules on Normal and Mutant Erythrocytes. Koippili, G.C., Spector, J., Sullivan, C. Kuypers, F.A., Labotka, R., Gallagher, P.G., Richie, K. Low, P.S. Blood 113, 6237-6245 (2009).
 

286.     Prostate-Specific Membrane Antigen (PSMA)-Targeted Imaging and Therapy of Prostate Cancer Using a PSMA Inhibitor as a Homing Ligand. Kularatne, S.A., Wang, K., Santhapuram, H.K.R., Low, P.S. Molecular Pharmaceutics 6, 780-789 (2009).
 

274.     Adducin forms a bridge between the erythrocyte membrane and its cytoskeleton and regulates membrane cohesion. Anong WA, Franco T, Chu, H, Weis, TL, Devlin EE, Bodine, DM, An, X, Narla, M and Low, PS. Blood 114, 1904-1912 (2009).
 

275.     Folate-Targeted Therapeutic and Imaging Agents for Cancer. Low, P.S. and Kularatne, S.A. Curr. Opin. Chem. Biol. 13, 256-262 (2009).
 

276.     Assessment of Disease Activity to Rheumatoid Arthritis Using a Novel Folate Targeted Radiopharmaceutical Folatescan™. Matteson, E.L., Lowe, V.J., Prendergast, F.G., Crowson, D.S., Moder, K.G., Morgenstern, D.E., Messmann, R.A., Low, P.S. Clinical and Experimental Rheumatology 27, 253-259 (2009).
 

277.     Design, Synthesis, and Pre-clinical Evaluation of Prostate-Specific Membrane Antigen (PSMA)-Targeted Tc-99m-Radioimaging Agents. Kularatne, S.A., Zhou, Z.G., Yang, J., Post, C.B., Low, P.S. Molecular Pharmaceutics 6, 790-800 (2009).
 

278.     Where Spectrin Snuggles with Ankyrin, Low, P.S. Blood 113, 5372-5373 (2009).
 

279.     Ligand-Targeted Delivery of Small Interfering RNAs to Malignant Cells and Tissues. Thomas, M., Kularatne, S.A., Qi, L., Kleindl, P., Leamon, C.P., Hansen, M.J., and Low, P.S. Ann. N.Y. Acad. Sci. 1175, 32–39 (2009).

280.     Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions. Yuan, Y., Nymoen, D.A., Dong, H.P., Bjorang, O., Shih, I.M., Low, P.S., Trope, C.G., Davidson, B. Human Pathology 40, 1453-1460 (2009).
 

281.     Functional Folate Receptor Alpha is Elevated in the Blood of Ovarian Cancer Patients. Basal E, Eghbali-Fatourechi GZ, Kalli KR, Hartmann LC, Goodman KM, Goode EL, Kamen BA, Low PS, Knutson KL. PLoS One. 4(7):e6292 (2009)295.
 

282.     Band 3 Catalyzes Sickle Hemoglobin Polymerization. Rotter, M. A., Chu, H., Low, P. S. Biophys Chem. 19 Oct 2009
 

283.     Role of Band 3 in Regulating Metabolic Flux of Red Blood Cells. Lewis I. A., Campanella, M. E., Markley, J. L., Low, P. S., Proc Natl Acad Sci U.S.A., 3 Nov 2009. 106(44):1851-20, Epub 21 Oct 2009
 

284.     Real Time, Noninvasive Imaging and Quantitation of the Accumulation of Ligand-targeted Drugs into Receptor-expressing Solid Tumors. Viashi E., Sturgis, J. E., Thomas, M., Low, P. S., Mol. Pharm. 2009 Nov-Dec;6(6):1868-75
 

285.     Strategy to Prevent Drug-related Hypersensitivity in Folate-targeted Hapten Immunotherapy of Cancer. Lu, Y., Klein, P. J., Westrick, E., Zu, L. C., Santhapuram, H. K., Bloomfield, A., Howard, S. J., Vianov, I. R., Elis, P. R., Low, P. S., Leamon, C.P., AAPS J., 2009 Sep,11(3):628-38
 

286.     Evaluation of Band 3 Diffusion and Compartment Size by Single Particle Tracking, Spector, J., Sullivan, C., Labotka, R., Ritchie, K., Kodippili, G.C., Low, P. S., Chemical Biochemistry, 42, 1851-1863 (2009)
 

287.     Targeting of nanoparticles: folate receptor., Kularatne, S.A., Low, P.S., Methods Mol Biol. 624:249-65 (2010).

288.     Imaging of Atherosclerosis in Apoliprotein E Knockout Mice: Targeting of a Folate-Conjugated Radiopharmaceutical to Activated Macrophages. Ayala-Lopez, W., Xia, W., Varghese, Low, P.S., J. Nuclear Med. 2010

289.     Deep-tissue Imaging of Intramolecular Fluorescence Resonance Energy-transfer Parameters, Vaibhav, G., Kulaatne, S., Low, P.S., Webb, Kevin J.,  Optics Letters, (35) 9 May 1, 2010

In Press

290.     Age-Dependent Changes in the Properties of Normal Human Red Blood Cells. Robert S. Franco, R. S., Campanella, M. E., Berber, L. A., Palascak, M. B., Joiner, C. H., Low, P.S. and Cohen, R. M.  Blood manuscript submitted

291.     Analysis of the Kinetics of Band 3 Diffusion in Human Erythroblasts during Assembly of the Erythrocyte Membrane Skeleton. Kodippili, G. C., Spector, J., Kang, G. E., Liu, H., Wickrema, A., Ritchie, K., Low, P.S.  in preparation.

292.     Identification of Glycolytic Enzymes Binding Proteins in the Human Erythrocyte Membrane. Campanella, M. E., Chu, H., Galan, J., Tao, A. and Low, P. S. in preparation